Compare MASI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MASI | CRL |
|---|---|---|
| Founded | 1989 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.0B |
| IPO Year | 2007 | 2000 |
| Metric | MASI | CRL |
|---|---|---|
| Price | $137.81 | $215.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | $188.80 | ★ $193.17 |
| AVG Volume (30 Days) | ★ 745.3K | 629.2K |
| Earning Date | 02-24-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,182,000,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.83 | $1.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 38.48 | N/A |
| 52 Week Low | $125.94 | $91.86 |
| 52 Week High | $194.88 | $217.89 |
| Indicator | MASI | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 72.71 |
| Support Level | $125.94 | $194.93 |
| Resistance Level | $131.95 | $217.89 |
| Average True Range (ATR) | 3.39 | 5.26 |
| MACD | 0.88 | 0.90 |
| Stochastic Oscillator | 100.00 | 87.15 |
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.